Advanced search
Publication Cover
Expert Review of Vaccines Volume 10, 2011 - Issue 8
Submit an article Journal homepage
38
Views
2
CrossRef citations to date
0
Altmetric
Editorial

Provenge: combating prostate cancer with a vengeance?

Thomas Schwaab Assistant Professor of Urology, Roswell Park Cancer Institute, Buffalo NY 14263, USA
&
Roberto Pili Professor of Oncology, Roswell Park Cancer Institute, Buffalo, NY 14263, USA. [email protected]
Pages 1113-1114 | Published online: 09 Jan 2014

References

  • Bracarda S, Logothetis C, Sternberg CN, Oudard S. Current and emerging treatment modalities for metastatic castration-resistant prostate cancer. BJU Int.107(Suppl. 2), 13–20 (2011).
  • Schwaab T, Atzpodien J. Renal cell carcinoma. In: Strategies in Immunoadjuvant Therapies. Kirkwood J (Ed.). Dunitz Publishers, London, UK (2000).
  • Kantoff PW, Higano CS, Shore ND et al. Sipuleucel-T immunotherapy for castration-resistant prostate cancer. N. Engl. J. Med.363(5), 411–422 (2010).
  • Kantoff PW, Schuetz TJ et al. Overall survival analysis of a Phase II randomized controlled trial of a pxviral-based PSA-targeted immunotherapy in metastatic castration resistant prostate cancer. J. Clin. Oncol.28(7), 1099–1105 (2010).
  • DiPaola RS, Plante M, Kaufman H et al. A Phase I trial of pox PSA vaccines (PROSTVAC-VF) with B7–1, ICAM-1, and LFA-3 co-stimulatory molecules (TRICOM) in patients with prostate cancer. J. Transl. Med.3, 4 (2006).
  • Palucka K, Ueno H, Banchereau J. Recent developments in cancer vaccines. J. Immunol.186(3), 1325–1331 (2011).
  • Graddis TJ, McMahan CJ, Tamman J, Page KJ, Trager JB. Prostatic acid phosphatase expression in human tissues. Int. J. Clin. Exp. Pathol.4(3), 295–306 (2011).
  • Thumar JR, Kluger HM. Ipilimumab: a promising immunotherapy for melanoma. Oncology24(14), 1280–1288 (2010).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.